---
layout: archive
title: "Research Experiences"
permalink: /talks/
author_profile: true
---

<div style="text-align: justify; line-height: 1.8; font-family: Arial, sans-serif;">

  <!-- Project 1 -->
  <div style="margin-bottom: 40px;">
    <strong>1. Mendelian Randomization Analysis of Multiregional Psychiatric Disorders and Their Associated Symptoms</strong> (In progress)<br>
    <span style="font-size: 0.9em; color: #666;">- Jun. 2025 – Present</span><br>
    <span style="font-size: 0.9em; color: #666;">- Research assistant (Supervisor: Dr. <a href="https://orcid.org/0000-0002-5062-7843">Weijie Xie</a>), Shanghai Mental Health Center, Shanghai, China</span>
    
    <div style="margin: 15px 0;">
      <strong>Description:</strong><br>
      <strong>Psychiatric disorders</strong> (e.g., depression, anxiety, addiction) are a major global health challenge. These conditions often <strong>co-occur and share biological roots</strong>, such as neurotransmitter issues and inflammation. While studies show shared <strong>genetic risks</strong> across these disorders, the direct links between <strong>genes and symptoms</strong> remain unclear.
    </div>
    
    <div style="margin: 15px 0;">
      Utilizing publicly available <strong>genome-wide association study (GWAS)</strong> data by combining <strong>Mendelian randomization (MR)</strong> methods, <strong>gene/protein analysis (TWAS/PWAS)</strong>, and <strong>colocalization</strong>, <strong>we aim to develop a cross-disorder genetic causal map</strong> that highlights shared genetic influences on diverse psychopathological dimensions, 
and <strong>prioritize therapeutic targets</strong> with cross-diagnostic potential, grounded in causal evidence, to inform precision interventions for mental health conditions.
    </div>
    
    <div style="text-align: center; margin: 20px 0;">
      <img src='/files/个人网站-PWAS.png' alt="Manhattan Plot" style="width: 70%; border: 1px solid #ddd; border-radius: 5px;">
      <div style="font-size: 0.8em; color: #888; margin-top: 5px;">The Manhattan plot</div>
    </div>
  </div>

  <!-- Project 2 -->
  <div style="margin-bottom: 40px; border-top: 1px solid #eee; padding-top: 20px;">
    <strong>2. Comprehensive Single-cell Analysis of Microglia in Depression</strong> (Completed)<br>
    <span style="font-size: 0.9em; color: #666;">- Aug. 2024 – May. 2025</span><br>
    <span style="font-size: 0.9em; color: #666;">- Research assistant (Supervisor: Dr. <a href="https://orcid.org/0000-0002-5062-7843">Weijie Xie</a>), Shanghai Mental Health Center, Shanghai, China</span>
    
    <div style="margin: 15px 0;">
      <strong>Description:</strong><br>
      <strong>Major Depressive Disorder (MDD)</strong> is strongly linked to <strong>neuroimmune dysfunction</strong>, but the exact mechanisms of communication between <strong>microglia</strong> and <strong>GABAergic neurons</strong> remain unclear. 
    
    <div style="margin: 15px 0;">  
      Using <strong>single-nucleus RNA-seq data</strong> of MDD patients and healthy controls (sourced from the GEO database), we analyzed microglial subtypes and their interactions with GABAergic neurons and prioritized key genes and biomarkers using <strong>69 machine learning models</strong>, followed by <strong>Mendelian randomization (MR)</strong> to assess causality between microglial features and MDD risk.
    </div>
    
    <div style="margin: 15px 0;">
    Our study suggestted that impaired microglia subtypes—characterized by <strong>metabolic imbalances</strong> or <strong>chronic neuroinflammation</strong>—contribute to abnormal microglia-GABAergic neuron communication in MDD. These findings identify potential targets for restoring neuroimmune balance in MDD.
    </div>
    
    <div style="text-align: center; margin: 20px 0;">
      <img src='/files/个人网站-MG.png' alt="Simplified Workflow" style="width: 70%; border: 1px solid #ddd; border-radius: 5px;">
      <div style="font-size: 0.8em; color: #888; margin-top: 5px;">The simplified workflow</div>
    </div>
  </div>

  <!-- Project 3 -->
  <div style="margin-bottom: 40px; border-top: 1px solid #eee; padding-top: 20px;">
    <strong>3. Immune Mechanisms of the Comorbidity of SLE and MDD</strong> (Completed)<br>
    <span style="font-size: 0.9em; color: #666;">- Jul. 2023 – Jul. 2024</span><br>
    <span style="font-size: 0.9em; color: #666;">- Research assistant (Supervisor: Dr. Jiaoqiong Guan), Shanghai Mental Health Center, Shanghai, China</span>
    
    <div style="margin: 15px 0;">
      <strong>Description:</strong><br>
      Patients with <strong>systemic lupus erythematosus (SLE)</strong> face a higher risk of <strong>major depressive disorder (MDD)</strong>, yet the shared <strong>immune</strong> mechanisms underlying comorbidity progression remain elusive. 
    </div>
    
    <div style="margin: 15px 0;"> 
      SLE-MDD datasets from GEO underwent WGCNA and differential expression analysis to identify co-expressed modules. A panel of <strong>101 machine learning algorithms</strong> was applied to select hub genes and construct <strong>diagnostic models</strong>, followed by immune infiltration and functional enrichment analyses. The potential biomarker was validated using <strong>public single-cell RNA-seq data</strong>, <strong>immunohistochemistry</strong>, and <strong>Western blot</strong>.
    </div>
    
    <div style="margin: 15px 0;">
      As a result, we proposed an <strong>immune target</strong> that might underlie the shared immune pathogenesis driving comorbidity progression by influencing the function and number of <strong>T-cell subtypes</strong>. Targeting this pathway may offer novel therapeutic strategies to slow the concurrent progression of both diseases.
    </div>
    
    <div style="text-align: center; margin: 20px 0;">
      <img src='/files/3D-SLE.png' alt="3D Visualization" style="width: 70%; border: 1px solid #ddd; border-radius: 5px;">
      <div style="font-size: 0.8em; color: #888; margin-top: 5px;">3D Visualization of Single-cell Data Using scatterplot3d</div>
    </div>
  </div>

  <!-- Project 4 -->
  <div style="margin-bottom: 40px; border-top: 1px solid #eee; padding-top: 20px;">
    <strong>4. Microglial Autophagy in Alleviating Depression</strong> (In progress)<br>
    <span style="font-size: 0.9em; color: #666;">- Sep. 2020 – Jul. 2023</span><br>
    <span style="font-size: 0.9em; color: #666;">- Master's Degree Research (Supervisor: Prof. Dr. <a href="https://orcid.org/0000-0003-1875-5463">Wuyang Wang</a>), Xuzhou Medical University, Department of Anesthesiology, Xuzhou, Jiangsu Province, China</span>
    
    <div style="margin: 15px 0;">
      <strong>Description:</strong><br>
      <strong>Major depressive disorder (MDD)</strong> is a psychiatric condition characterized by depressed mood and anhedonia, various pro-inflammatory cytokines are released from <strong>microglia</strong>, leading to neuronal excitotoxicity, synaptic pruning, and demyelination, which impact mood and cognition in individuals. 
    </div>
    
    <div style="margin: 15px 0;">
      We employed various methods, including <strong>chronic restraint stress mouse models, lipopolysaccharide (LPS)-induced depression models (induced via lateral ventricle injection), transgenic knockout mouse models, primary microglia extraction and culture</strong>, depression-like behavioral analysis, Western blotting (WB), polymerase chain reaction (PCR), immunofluorescence staining, Golgi staining, 3D reconstruction technology, and bioinformatic analysis.
    </div> 
    
    <div style="margin: 15px 0;">
      Our research focused on <strong>the molecular mechanisms of microglia in MDD</strong> and, based on this, proposed <strong>a potential targeted drug</strong>.
    </div>
    
    <div style="text-align: center; margin: 20px 0;">
      <img src='/images/research6.png' alt="Microglia Morphology" style="width: 70%; border: 1px solid #ddd; border-radius: 5px;">
      <div style="font-size: 0.8em; color: #888; margin-top: 5px;">
        Microglia in the LPS group exhibited enlarged cell bodies and shortened processes, indicative of an activated state. Conversely, treatment with our drug induced microglial morphology resembling a resting state.
      </div>
    </div>
  </div>

</div>
